The contributing factors to mean pulmonary artery pressure in idiopathic pulmonary fibrosis

Shinichi Arizono (Hamamatsu/Shizuoka, Japan), Shinichi Arizono, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Kazuyuki Tabira, Ryo Kozu

Source: International Congress 2016 – Latest insights into chronic care
Session: Latest insights into chronic care
Session type: Thematic Poster
Number: 3755
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shinichi Arizono (Hamamatsu/Shizuoka, Japan), Shinichi Arizono, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Kazuyuki Tabira, Ryo Kozu. The contributing factors to mean pulmonary artery pressure in idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 3755

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012


Acute exacerbation of idiopathic pulmonary fibrosis is associated to increase of pulmonary artery systolic pressure (PAPs)
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Right ventricular REMODELING in idiopathic pulmonary fibrosis with or without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013

Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

Sildenafil decreases the contractile response to serotonin (5HT) in pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary hypertension in idiopathic pulmonary fibrosis: correlation to pulmonary function and exercise parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Accelerated ageing in idiopathic pulmonary fibrosis and pulmonary hypertension
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018


Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012



Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Right ventricular dysfunction in pulmonary hypertension with combined pulmonary fibrosis and emphysema syndrome
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 47:1445-1451
Year: 2016



Exercise limitation in idiopathic pulmonary arterial hypertension (IPAH): there‘s more to it than just the pulmonary circulation
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005

Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005


Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007



Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007